UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 3, 2023 4:00 P.M.
Form:
F-3
CIK:
0001534248
Company Name:
Chemomab Therapeutics Ltd.
File Number:
333-275002